1. From the F.M. Kirby Center for Molecular Ophthalmology, Department of Ophthalmology, University of Pennsylvania Scheie Eye Institute, Philadelphia, Pennsylvania; the
2. Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania; and
3. Sirtris Pharmaceuticals, Cambridge, Massachusetts.